Posts for Ticker ‘WERN’

Top Day Trader Alerts (ALKS, LLY, SNY, MRK, SPPI, LXK, BSX, JDAS, IDIX, PKG, CVBF, WERN)

These are some of this morning’s top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis at VSInvestor.com:

Alkermes Inc. (Nasdaq: ALKS) shares are ones to watch for volume upside following positive study results that may also affect shares of Eli Lilly & Co. (NYSE: LLY) and Sanofi Aventis (NYSE: SNY).

Merck & Co. (NYSE: MRK) shares are up over 3% after it beat EPS by 6 cents a share and reaffirmed fiscal 2009 guidance.

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) shares are rising in premarket trade after getting FDA fast-track status for a bladder cancer candidate.

Lexmark International Group Inc. (NYSE: LXK) shares are ones to watch for volume downside after it missed expectations by 5 cents a share and guided Q3 EPS lower.

JDA Software Group Inc. (Nasdaq: JDAS) are ones to watch for volume upside after it posted  a 17-cent a share EPS beat.

Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) shares are ones to watch for volume downside after it missed EPS expectations by 3 cents a share.

Packaging Corp. of America (NYSE: PKG) shares are ones to watch for volume upside following a 12-cent EPS beat.

Boston Scientific (NYSE: BSX) is up strongly in early premarket trade on stronger-than-expected earnings.

CVB Financial Corp. (Nasdaq: CVBF) shares are ones to watch for downside after it announced a stock offering.

Werner Enterprises Inc. (Nasdaq: WERN) are ones to watch for volume downside on concerns about a revenue miss.

-The 24/7 Wall St. Team

Posted on: July 21, 2009 – 7:40 am in Pre-Market Activity, Trading Alert, , , , , , , , , , , ,

Top Analyst Upgrades and Downgrades (AWK, BEAT, CHKP, IACI, MVL, MYGN, NVO, SYMC, WERN)

These are the top pre-market analyst upgrades and downgrades this Wednesday morning in early trading.

  • American Water Works (AWK) Started as Buy at Brean Murray.
  • CardioNet (BEAT) Cut to Hold at Citigroup; Cut to Hold at boutique firm Roth.
  • Checkpoint Software (CHKP) Cut to Neutral at JPMorgan.
  • IAC/Interactive (IACI) Started as Outperform at Oppenheimer.
  • Marvel Entertainment (MVL) Raised to Overweight at JPMorgan.
  • Myriad Genetics (MYGN) down on downgrades from RBC, Oppenheimer, Citigroup, Morgan Joseph, and more.
  • Novo Nordisk (NVO) Raised to Buy at Goldman Sachs.
  • Symantec (SYMC) Started as Outperform at JMP Securities.
  • Werner Enterprises (WERN) Raised to Overweight at JPMorgan.

After today, we’d expect analyst coverage to start getting this until at least next Tuesday because of the shortened week.  We have already seen the effects of fewer participants this week, particularly after such a stellar quarter that just ended yesterday.

Jon C. Ogg
July 1, 2009

Posted on: July 1, 2009 – 7:11 am in Analyst Calls, , , , , , , , ,

Early-Bird Analyst Upgrades & Downgrades (ANN, CSUN, VRGY, CVC, KNX, OSK, WERN)

As this is last week of August, the daily upgrades and downgrades are rather thin as firms are starting to run on skeleton crews for one of the lightest news weeks of the year.  Here are today’s early-bird analyst upgrades and downgrades:

  • Ann Taylor (ANN) Raised to Hold from Sell at Citigroup.
  • China Sunergy (CSUN) Raised to Buy at Jefferies.
  • Verigy (VRGY) Raised to Hold at S&P.
  • Cablevision (CVC) Cut to Sell at Citigroup.
  • Knight Transportation (KNX) Cut to Market Perform at Wachovia.
  • Oshkosh (OSK) Cut to Sell at S&P.
  • Werner Enterprises (WERN) Cut to Market Perform at Wachovia.

Jon C. Ogg
August 25, 2008

Posted on: August 25, 2008 – 6:25 am in Analyst Calls, , , , , , ,

Many Monday Pre-Market Downgrades (CEG, FIS, FISV, DNA, KBW, NKE, PSO, SHW, SWIR, SWK, WERN, WIT)

These are among the top analyst Downgrades or negative analyst calls affecting shares this Monday morning in pre-market trading:

  • Constellation Energy (NYSE: CEG) Downgraded to Underperform at Jefferies.
  • Fidelity National (NYSE: FIS) Cut to Perform at Oppenheimer.
  • Fiserv (NASDAQ: FISV) Cut to Perform at Oppenheimer.
  • Genentech (NYSE: DNA) Raised to Overweight at Lehman.
  • KBW (NYSE: KBW) Cut to Market Perform at FBR.
  • Nike (NYSE: NKE) Cut to Neutral at HSBC.
  • Pearson plc (NYSE: PSO) Cut to Sell at Deutsche Bank.
  • Satyam Computer Services (NYSE: SAY) Cut to Equal Weight at Morgan Stanley; Cut to Underperform at Credit Suisse.
  • Sherwin Williams (NYSE: SHW) Cut to Sell at Goldman Sachs.
  • Sierra Wireless (NASDAQ: SWIR) Target cut to $20 from $25 at CIBC.
  • Stanley Works (NYSE: SWK) Cut to Hold at Deutsche Bank.
  • Werner Enterprises (NASDAQ: WERN) Cut to Sell at UBS.
  • WIPRO (NYSE: WIT) Cut to Underperform at Credit Suisse.

Jon C. Ogg
July 21, 2008

Posted on: July 21, 2008 – 7:52 am in Analyst Calls, , , , , , , , , , , ,

Pre-Market Stock News (January 23, 2008)

We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and guidance.  There are of course drug developments and other contracts awards.  Below is a snapshot of some of the key data we saw affecting shares in pre-market trading:

  • Abbott Laboratories (ABT) $0.93 EPS versus $0.92 estimate; sees Q1 EPS $0.61 to $0.63 versus $0.65 estimates and sees 2008 EPS $3.20 to $3.25 versus $3.22 estimate.
  • Advanced Energy Industries Inc. (NASDAQ: AEIS) traded down over 10% after after it lowered guidance.
  • Air Products (APD) $1.16 EPS vs $1.13 estimates. 
  • Apple Inc. (AAPL) trading down 10% after it posted $1.76 EPS on $9.6 Billion revenues; Estimates were $1.62 EPS on revenues of $9.47 Billion; Guidance for next quarter is $0.94 EPS and revenues $6.8 Billion versus estimates of $1.09 EPS on $6.98 Billion in revenues.
  • Baidu.com (BIDU) announces the formal launch of its Japanese language search engine run by its Japanese subsidiary.
  • CheckPoint Software (CHKP) trading up almost 5% after $0.46 EPS versus $0.45 est.; Revenues $206.7M vs. $202.3M est.;
  • CNH Global (CNH) $0.50 EPS versus $0.60 estimate.
  • Coach (COH) $0.69 EPS vs $0.68 estimate; noted weak mall traffic and decline in average transaction size.
  • EntreMed (ENMD) is starting its Phase II study with its MKC-1 cell cycle inhibitor in ovarian cancer and advanced endometrial cancer.
  • Ethan Allen (ETH) posted $0.70 EPS versus $0.68 estimate.
  • Foster Wheeler (FWLT) trades ex-split to reflect a 2 for 1 stock split.
  • General Dynamics (GD) $1.42 EPS vs. $1.41 estimate; sees 2008 EPS $5.55 to $5.65 versus $5.73 estimate.
  • HOKU Scientific Inc. (HOKU) traded down 10% after earnings beat but guidance was deemed light.
  • INX (INXI) awarded Department of Defense contract to provide up to $21 million in support  of a Cisco Systems network pact.
  • Martek Biosciences (MATK) noted a December publication showed its DHA may help in late-onset Alzheimer’s, although NIH study results will be in 2010.
  • Parametric (PMTC) $0.26 EPS vs. $0.23 estimate; sees next quarter $0.24 to $0.28 vs. $0.26 estimate; sees 2008 EPS $1.17 to $1.27 vs. $1.16 estimate (revenue in-line).
  • Praxair (PX) $0.98 EPS vs $0.97 estimate.
  • Qualcomm (QCOM) expanded relationship with Motorola for chipsets into certain UMTS 3G handsets in 2008 and 2009.
  • RLI Corp. (RLI) $1.22 EPS versus $1.05 estimate.
  • Rockwell Automation (ROK) $1.04 EPS vs. $1.01 estimates; guides 200 EPS $4.25 to $4.45 versus $4.38 estimate.
  • Southwest Airlines (LUV) $0.12 EPS vs. $0.10 estimate ; reigned in 2008 growth plans to 4%-5% capacity.
  • Texas Instruments Inc. (TXN) has posted earnings of $0.54 EPS and revenues of $3.56 Billion; analysts pegged at $0.52 EPS on $3.58 Billion in revenues; sees Next quarter $0.43 to $0.49 EPS on revenues of $3.27 to $3.55 Billion versus estimates of $0.45 EPS on $3.41 Billion in revenues.
  • TJX Companies (TJX) was Jim Cramer’s retail pick on CNBC’s MAD MONEY last night.
  • United Tech (UTX) $1.08 EPS vs. $1.06 estimate; sees 2008 $4.65 to $4.85 versus $4.85 estimate.
  • Vertex Pharmaceuticals (VRTX) will begin Phase III evaluation of telaprevir for its lead investigational hepatitis C protease inhibitor.
  • WellPoint (WLP) $1.51 EPS versus $1.51 estimate.
  • Werner Enterprises (WERN) $0.28 EPS vs. $0.28 estimate.

Jon C. Ogg
January 23, 2008

Posted on: January 23, 2008 – 7:58 am in Pre-Market Activity, , , , , , , , , , , , , , , , , , , , , , , , , ,

Earlybird Analyst Calls (June 19, 2007)

ACLI cut to Hold at Deutsche Bank.
ACOR raised to Buy at B of A.
AGO cut to Underweight at JPMorgan.
ANAD started as Buy at Oppenheimer.
ANET cut to Neutral at Baird.
ATHR started as Buy at Oppenheimer.
AV cut to Mkt Perform at JMP Securities.
BAC raised to Buy at UBS.
BEAS cut to Neutral at UBS.
CHD started as Buy at Sun Trust Robinson Humphrey.
CI raised to Neutral at B of A.
EGLE started as Neutral at JPMorgan.
EPIC started as Buy at Sun Trust Robinson Humphrey.
GNK started as Overweight at JPMorgan.
GNTX raised to Buy at B of A.
KNX raised to Outperform at Wachovia.
LCC raised to Neutral at UBS.
MCHP cut to Mkt Perform at Piper Jaffray.
QMAR started as Neutral at JPMorgan.
SDXC started as Buy at Kaufman Bros.
SKH started as Buy at Jefferies.
SRE raised to Buy at Citigroup.
TZIX started as Buy at Deutsche Bank.
WERN raised to Outperform at Wachovia.
YRCW cut to Mkt Perform at Wachovia.

Jon C. Ogg
June 19, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 19, 2007 – 6:20 am in Analyst Calls, , , , , , , , , , , , , , , , , , , , , , , , ,